Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2000
12/27/2000EP1061910A1 Use of alpha-rar antagonists for inhibition of mucin secretion
12/27/2000EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
12/27/2000EP1061873A1 Use of corneal hardening agents in enzyme orthokeratology
12/27/2000EP1061802A1 Topical carbamazepine formulations and methods of use
12/27/2000EP1061800A1 Compositions and methods for modulating vascularization
12/27/2000EP0671909B1 Syndecan stimulation of cellular differentiation
12/27/2000CN1278177A Neovascularization promoters
12/27/2000CN1278174A Nicotine compositions and method for formulation thereof
12/27/2000CN1278164A Solid state solutions and dispersions of poorly water soluble drugs
12/27/2000CN1278158A Synergistic analgestic combination of opioid analgsic and cyclooxygenase-2
12/27/2000CN1277841A Quick absorption liquid composite
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166090 Prevention atherosclerosis; administering transforming growth factor
12/26/2000US6166086 Small molecules that increase the conversion of food to body weight gain
12/26/2000US6166073 Combinations of DP and FP type prostaglandins for lowering IOP
12/26/2000US6166061 Methods and formulations for modulating the human sexual response
12/26/2000US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation
12/26/2000US6166043 Insulin sensitivity enhancer such as pioglitazone in combination with a biguanide such as metformin
12/26/2000US6166042 Pharmaceutical composition
12/26/2000US6166039 Peripherally active anti-hyperalgesic opiates
12/26/2000US6166017 Method of using ketoconazole and related substances in medicaments for treatment of type II diabetes and methods of treating same
12/26/2000US6166008 Treatment of schizophrenia with ampakines and neuroleptics
12/26/2000US6166002 Substituted phenylalkenoylguanidines, process for their preparation, and their use in medicaments and in diagnostics
12/26/2000US6166000 For treating breast cancer
12/26/2000US6165987 A veterinary parasciticide dose containing a praziquantel, at least one macrolide anthelmintic selected from avermectins and milbemycins and a solvent selected from glycerol formal, ethyl lactate, benzyl alcohol and n-metyl-2-pyrrollidone
12/26/2000US6165975 Microdose therapy
12/26/2000US6165974 Administering an effective dose of a pharmaceutical preparation comprising at least two coagulation factors which are components of a prothrombinase or of a pro-prothrombinase to the patient for the treatment of acute bleeding
12/26/2000US6165772 Simple and cost-effective preparation of vehicle for delivery of dna, rna, protein, peptide nucleic acids, or lipophilic drugs
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165513 Film-coated tablet for improved upper gastrointestinal tract safety
12/26/2000US6165503 Preparing gelled beads of a polyanionic polysaccharide which are cross-linked with a polyvalent cation, forming capsules having polycationic-polyanion membrane of polycationic polysaccharide on gelled beads, culturing the product capsule
12/26/2000US6165484 EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
12/26/2000US6165481 Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000US6165462 Sugar kinase
12/26/2000US6164282 Methods for restoring and/or enhancing accommodation in pseudo phakia
12/26/2000US6164281 Method of making and/or treating diseases characterized by neovascularization
12/23/2000CA2312432A1 Use of melatoninergic ligands to obtain pharmaceutical compositions for the prevention or treatment of pathologies in the gastrointestinal system
12/21/2000WO2000077517A1 Protein localization assays for toxicity and antidotes thereto
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077246A2 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
12/21/2000WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000WO2000077206A2 The myostatin gene promoter and inhibition of activation thereof
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077190A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000WO2000077184A1 Caspase-8 crystals, models and methods
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077035A2 Novel potassium channels and genes encoding these potassium channels
12/21/2000WO2000076962A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000WO2000076961A1 Inhibitors of aspartyl protease
12/21/2000WO2000076587A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000WO2000076545A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076524A1 Combination cancer therapy comprising adenosine and deaminase enzyme inhibitor
12/21/2000WO2000076521A1 Antiviral indoleoxoacetyl piperazine derivatives
12/21/2000WO2000076519A1 Sulfonamide and sulfamide substituted imidazoquinolines
12/21/2000WO2000076509A1 Nasal delivery of apomorphine
12/21/2000WO2000076500A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction
12/21/2000WO2000076499A2 Neuroprotective and retinoprotective ophthalmologic medicines
12/21/2000WO2000076497A1 Cancer therapy
12/21/2000WO2000076487A2 Use of paclitaxel and steriod derivatives as aromatase inhibitors for the treatment of cancer
12/21/2000WO2000076482A1 Novel formulations comprising lipid-regulating agents
12/21/2000WO2000076318A1 Nitric oxide donors for inducing neurogenesis
12/21/2000WO2000076316A1 Methods related to metabolism of parasites and mycobacteria
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000050033A3 Anti-tumor synergetic composition
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000048621A3 Methods and compositions for regulating protein-protein interactions
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000040701A3 Non-myeloablative tolerogenic treatment
12/21/2000WO2000036421A8 Use of vascular endothelial growth factor (vegf)
12/21/2000WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
12/21/2000DE19928021A1 New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2377431A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000CA2376933A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000CA2376921A1 Nasal delivery of apomorphine
12/21/2000CA2376909A1 Neuroprotective and retinoprotective ophthalmologic medicines
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376715A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376630A1 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
1 ... 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 ... 1151